As biological proof of concept that ROS contribute to MFS aneurysm formation, Fbn1C1039G/+ mice treated with the unspecific NADPH oxidase inhibitor apocynin exhibited reduced ROS production, which directly correlated with decreased protease activity/ECM destruction and diminished aneurysm formation. The gene discussed is FMO5; the disease is aneurysm.